143 related articles for article (PubMed ID: 15837921)
1. Absence of a desmopressin response after therapeutic expression of factor VIII in hemophilia A dogs with liver-directed neonatal gene therapy.
Xu L; Nichols TC; Sarkar R; McCorquodale S; Bellinger DA; Ponder KP
Proc Natl Acad Sci U S A; 2005 Apr; 102(17):6080-5. PubMed ID: 15837921
[TBL] [Abstract][Full Text] [Related]
2. Unravelling the effect of blood group on FVIII:C levels and response to DDAVP in 20 males with a single genotype (Twillingate Variant) causing Haemophilia A.
Shu M; Malcolmson C; Bouskill V; Stain AM; Wakefield C; Blanchette VS; Carcao MD
Haemophilia; 2024 Jan; 30(1):116-122. PubMed ID: 38037243
[TBL] [Abstract][Full Text] [Related]
3. Helper-dependent adenoviral gene therapy mediates long-term correction of the clotting defect in the canine hemophilia A model.
McCORMACK WM; Seiler MP; Bertin TK; Ubhayakar K; Palmer DJ; Ng P; Nichols TC; Lee B
J Thromb Haemost; 2006 Jun; 4(6):1218-1225. PubMed ID: 16706963
[TBL] [Abstract][Full Text] [Related]
4. Desmopressin in moderate hemophilia A patients: a treatment worth considering.
Loomans JI; Kruip MJHA; Carcao M; Jackson S; van Velzen AS; Peters M; Santagostino E; Platokouki H; Beckers E; Voorberg J; van der Bom JG; Fijnvandraat K;
Haematologica; 2018 Mar; 103(3):550-557. PubMed ID: 29305412
[TBL] [Abstract][Full Text] [Related]
5. Translational Potential of Immune Tolerance Induction by AAV Liver-Directed Factor VIII Gene Therapy for Hemophilia A.
Samelson-Jones BJ; Arruda VR
Front Immunol; 2020; 11():618. PubMed ID: 32425925
[TBL] [Abstract][Full Text] [Related]
6. The Immune Response to the fVIII Gene Therapy in Preclinical Models.
Patel SR; Lundgren TS; Spencer HT; Doering CB
Front Immunol; 2020; 11():494. PubMed ID: 32351497
[TBL] [Abstract][Full Text] [Related]
7. Identification of the Efficient Enhancer Elements in FVIII-Padua for Gene Therapy Study of Hemophilia A.
Xiao R; Chen Y; Hu Z; Tang Q; Wang P; Zhou M; Wu L; Liang D
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612447
[TBL] [Abstract][Full Text] [Related]
8. Severe Hemophilia A in a Male Old English Sheep Dog with a C→T Transition that Created a Premature Stop Codon in Factor VIII.
Lozier JN; Kloos MT; Merricks EP; Lemoine N; Whitford MH; Raymer RA; Bellinger DA; Nichols TC
Comp Med; 2016; 66(5):405-411. PubMed ID: 27780008
[TBL] [Abstract][Full Text] [Related]
9. Ultrasound-mediated gene delivery specifically targets liver sinusoidal endothelial cells for sustained FVIII expression in hemophilia A mice.
Lawton SM; Manson MA; Fan MN; Chao TY; Chen CY; Kim P; Campbell C; Cai X; Vander Kooi A; Miao CH
Mol Ther; 2024 Apr; 32(4):969-981. PubMed ID: 38341614
[TBL] [Abstract][Full Text] [Related]
10. Cellular stress and coagulation factor production: when more is not necessarily better.
Chen Z; Herzog RW; Kaufman RJ
J Thromb Haemost; 2023 Dec; 21(12):3329-3341. PubMed ID: 37839613
[TBL] [Abstract][Full Text] [Related]
11. IL-15 blockade and rapamycin rescue multifactorial loss of factor VIII from AAV-transduced hepatocytes in hemophilia A mice.
Butterfield JSS; Yamada K; Bertolini TB; Syed F; Kumar SRP; Li X; Arisa S; Piñeros AR; Tapia A; Rogers CA; Li N; Rana J; Biswas M; Terhorst C; Kaufman RJ; de Jong YP; Herzog RW
Mol Ther; 2022 Dec; 30(12):3552-3569. PubMed ID: 35821634
[TBL] [Abstract][Full Text] [Related]
12. Transplanting FVIII/ET3-secreting cells in fetal sheep increases FVIII levels long-term without inducing immunity or toxicity.
Rodriguez M; Trevisan B; Ramamurthy RM; George SK; Diaz J; Alexander J; Meares D; Schwahn DJ; Quilici DR; Figueroa J; Gautreaux M; Farland A; Atala A; Doering CB; Spencer HT; Porada CD; Almeida-Porada G
Nat Commun; 2023 Jul; 14(1):4206. PubMed ID: 37452013
[TBL] [Abstract][Full Text] [Related]
13. Development of alternative gene transfer techniques for
Noda M; Tatsumi K; Matsui H; Matsunari Y; Sato T; Fukuoka Y; Hotta A; Okano T; Kichikawa K; Sugimoto M; Shima M; Nishio K
Regen Ther; 2021 Dec; 18():347-354. PubMed ID: 34584911
[TBL] [Abstract][Full Text] [Related]
14. Hemophilia A in a litter of Border Collies caused by a one base pair deletion in the F8 gene.
Brockmann M; Mensing N; von Luckner J; Müller E; Kehl A
Vet Clin Pathol; 2023 Dec; 52(4):607-612. PubMed ID: 38104983
[TBL] [Abstract][Full Text] [Related]
15. AAV gene therapy in companion dogs with severe hemophilia: Real-world long-term data on immunogenicity, efficacy, and quality of life.
Doshi BS; Samelson-Jones BJ; Nichols TC; Merricks EP; Siner JL; French RA; Lee BJ; Arruda VR; Callan MB
Mol Ther Methods Clin Dev; 2024 Mar; 32(1):101205. PubMed ID: 38374963
[TBL] [Abstract][Full Text] [Related]
16. Efficient and safe correction of hemophilia A by lentiviral vector-transduced BOECs in an implantable device.
Olgasi C; Borsotti C; Merlin S; Bergmann T; Bittorf P; Adewoye AB; Wragg N; Patterson K; Calabria A; Benedicenti F; Cucci A; Borchiellini A; Pollio B; Montini E; Mazzuca DM; Zierau M; Stolzing A; Toleikis PM; Braspenning J; Follenzi A
Mol Ther Methods Clin Dev; 2021 Dec; 23():551-566. PubMed ID: 34853801
[TBL] [Abstract][Full Text] [Related]
17. Genotype-Dependent Response to Desmopressin in Hemophilia A and Proposal of a Predictive Response Score.
Guillet B; Pawlowski M; Boisseau P; Répessé Y; Beurrier P; Bayart S; Delavenne X; Trossaërt M; Lenting PJ
Thromb Haemost; 2024 Jun; ():. PubMed ID: 38759975
[TBL] [Abstract][Full Text] [Related]
18. Ectopic clotting factor VIII expression and misfolding in hepatocytes as a cause for hepatocellular carcinoma.
Kapelanski-Lamoureux A; Chen Z; Gao ZH; Deng R; Lazaris A; Lebeaupin C; Giles L; Malhotra J; Yong J; Zou C; de Jong YP; Metrakos P; Herzog RW; Kaufman RJ
Mol Ther; 2022 Dec; 30(12):3542-3551. PubMed ID: 36242517
[TBL] [Abstract][Full Text] [Related]
19. Investigating Optimal Autologous Cellular Platforms for Prenatal or Perinatal Factor VIII Delivery to Treat Hemophilia A.
Stem C; Rodman C; Ramamurthy RM; George S; Meares D; Farland A; Atala A; Doering CB; Spencer HT; Porada CD; Almeida-Porada G
Front Cell Dev Biol; 2021; 9():678117. PubMed ID: 34447745
[TBL] [Abstract][Full Text] [Related]
20. Tachyphylaxis and reproducibility of desmopressin response in perioperative persons with nonsevere hemophilia A: implications for clinical practice.
Romano LGR; Schütte LM; van Hest RM; Meijer K; Laros-van Gorkom BAP; Nieuwenhuizen L; Eikenboom J; Heubel-Moenen FCJI; Uitslager N; Coppens M; Fijnvandraat K; Driessens MHE; Polinder S; Cnossen MH; Leebeek FWG; Mathôt RAA; Kruip MJHA;
Res Pract Thromb Haemost; 2024 Mar; 8(3):102367. PubMed ID: 38660455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
